Variant report
Variant | nsv585582 |
---|---|
Chromosome Location | chr20:15234479-15252715 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6034134 | chr20:15234479-15234480 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs529648738 | chr20:15234515-15234516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547734430 | chr20:15234520-15234521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369801343 | chr20:15234539-15234540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566249060 | chr20:15234601-15234602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527349288 | chr20:15234639-15234640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571060262 | chr20:15234659-15234660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78993334 | chr20:15234670-15234671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570532016 | chr20:15234732-15234733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139720643 | chr20:15234739-15234740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10485520 | chr20:15234769-15234770 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs189334129 | chr20:15234776-15234777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565616325 | chr20:15234807-15234808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111643871 | chr20:15234824-15234825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535873944 | chr20:15234852-15234853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554174792 | chr20:15234865-15234866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113532919 | chr20:15234902-15234903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs180882817 | chr20:15234962-15234963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140590835 | chr20:15234986-15234987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4580449 | chr20:15235072-15235073 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs559531178 | chr20:15235080-15235081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4399780 | chr20:15235142-15235143 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs4371414 | chr20:15235247-15235248 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs543953290 | chr20:15235256-15235257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6079719 | chr20:15235277-15235278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562245503 | chr20:15235295-15235296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529513461 | chr20:15235297-15235298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146936985 | chr20:15235299-15235300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6074863 | chr20:15235300-15235301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564149841 | chr20:15235316-15235317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77996820 | chr20:15235322-15235323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572765708 | chr20:15235352-15235353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111767648 | chr20:15235417-15235418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4473454 | chr20:15235424-15235425 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs189408271 | chr20:15235492-15235493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73614403 | chr20:15235503-15235504 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs549920480 | chr20:15235555-15235556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568379523 | chr20:15235600-15235601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75017119 | chr20:15235601-15235602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74179767 | chr20:15235608-15235609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73101205 | chr20:15235663-15235664 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs141512331 | chr20:15235698-15235699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369060583 | chr20:15235732-15235733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181822560 | chr20:15235773-15235774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547842167 | chr20:15235796-15235797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544026454 | chr20:15235805-15235806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73262749 | chr20:15235839-15235840 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs186184264 | chr20:15235850-15235851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529595431 | chr20:15235855-15235856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555362064 | chr20:15235881-15235882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
Multiple sclerosis | 20663923 | CNVD |
Schizophrenia | 20663923 | CNVD |
brain infarct | 20663923 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164920 | CNVD |
Schizophrenia | 23813976 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:15234000-15236000 | Weak transcription | Gastric | stomach |
2 | chr20:15236000-15236200 | Enhancers | Gastric | stomach |
3 | chr20:15237200-15238400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr20:15237600-15238400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr20:15237800-15238200 | Enhancers | HMEC | breast |
6 | chr20:15244200-15245200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr20:15245200-15246000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr20:15245200-15246600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr20:15245400-15246200 | Enhancers | Fetal Intestine Large | intestine |
10 | chr20:15245400-15246200 | Enhancers | Fetal Intestine Small | intestine |
11 | chr20:15245800-15246600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr20:15245800-15246800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr20:15246200-15247000 | Weak transcription | Fetal Intestine Large | intestine |
14 | chr20:15246400-15249600 | Enhancers | GM12878-XiMat | blood |
15 | chr20:15247000-15247200 | Enhancers | Fetal Intestine Large | intestine |
16 | chr20:15248600-15250000 | Enhancers | Primary B cells from peripheral blood | blood |
17 | chr20:15249600-15250000 | Flanking Active TSS | GM12878-XiMat | blood |
18 | chr20:15250000-15250200 | Enhancers | GM12878-XiMat | blood |